Latest News
AstraZeneca signs major deal with Grunenthal over Zurampic
Pharmaceutical and biologics company AstraZeneca announced on Thursday that it has entered into a licensing agreement with Grünenthal GmbH for the exclusive rights to Zurampic (lesinurad) in Europe and Latin America.
London pre-open: Stocks seen lower ahead of OPEC, ECB announcement
London stocks were seen opening lower on Thursday following mixed leads from the US and Asia, as investors looked to the OPEC meeting and the ECB rate announcement.
Johnson Matthey full year hit by impairment charge; sees new year in line
A £141m impairment and restructuring charge hit pre-tax profits at chemicals and sustainable technology group Johnson Matthey, which fell to £386. 3m from £495m in a “difficult macroeconomic environment”.
Thursday newspaper round-up: BHS, Brexit, OPEC
The father and son property tycoons who helped Dominic Chappell to fund his doomed acquisition of BHS have been called to appear before the two House of Commons select committees investigating its collapse. Guy and Alex Dellal, the son and grandson of legendary property magnate 'Black Jack' Dellal, who run Allied Commercial Exports, loaned Mr Chappell's Retail Acquisitions vehicle £35m in order to help buy BHS. - Telegraph.
Johnson Matthey profits pummelled, AstraZeneca licenses gout drug
London open The FTSE 100 is predicted to fall 12 points on Thursday, extending the losses from the previous session that left the index at 6,191. 93.